Related Experiment Videos
Ethnicity, language, specialty care, and quality of diabetes care
Tung T Nguyen1, Nicholas A Daniels, Ginny L Gildengorin
1Division of General Internal Medicine, Department of Medicine, Medical Effectiveness Research Center for Diverse Populations, University of California, San Francisco, California, USA.
Objective:
To investigate ethnicity, language, specialty care, and quality of diabetes care in one medical center.
Methods:
Retrospective review of computerized records of patients with diabetes age > or = 50 years who were regularly cared for in general medicine, family practice, or diabetes clinics from 1997 to 2000. Measures of processes of care were tests for creatinine, cholesterol, hemoglobin A1C (HbA1C), and microalbumin; ophthalmologic care; and total visits. Intermediate outcomes were average systolic blood pressure (SBP) < 140 mm Hg and HbA1C < 8%.
Results:
Among 1323 patients, test rates for creatinine, cholesterol, microalbuminuria, and HbA1C were 76.6%, 54.7%, 17.2%, 78.8%, respectively. Only 31.0% had ophthalmology visits, 57.4% had SBP < 140 mm Hg, and 62.0% had HbA1C < 8%. In multivariate analyses, African Americans, Asians, and Latinos received more tests and had more total visits than Whites. Intermediate outcomes were similar except that Asians were more likely (odds ratio [OR] = 1.78, 95% confidence interval [CI] 1.26-2.50) to have SBP < 140 mm Hg. Limited English proficient patients had more total visits (7.0) than English speakers (6.5) (P = .01). Compared to patients with only primary care, patients with a diabetes specialist had more microalbuminuria (OR 3.04, 95% CI 1.87-4.95) and HbA1C (OR 1.91, 1.12-3.26) tests, while those with both types of care were more likely to have each of the five process measures but less likely to have HbA1C < 8%.
Conclusions:
Quality of diabetes care was suboptimal for most patients. No ethnic disparity was seen in intermediate outcomes, which may have been achieved through more tests and visits. Combined care by primary and diabetes clinicians may be optimal.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis